NASDAQ:ATOS I anticipate a pullback to $0.85 as the Relative Strength Index (RSI) indicates an overbought condition. Based on Elliott Waves theory, a correction is expected, followed by the emergence of the fifth leg. Following the pullback, if the price surpasses the psychological resistance level of $1, there are three potential price targets: $1.15, $1.30,...
We can see that the weekly chart is showing some exhaustion on the sell pressure. The daily has a bit of a heartbeat today breaking over the 20ema/ma. Looking to see the weekly SARs flip underneath to support price, and a break over the T Line (EMA8) on the weekly to confirm a trend change. If there is a solid break, targets (based on current price but will...
Investment opportunity local bottom is formed, targeting $10/$15 this yr
After a schoolbook Head and Shoulders chart pattern that i warned you here: Now ATOS Atossa Therapeutics found support and it`s ready to move higher. My target is the 4.5 resistance.
It seems like ATOS Atossa Therapeutics is forming a Head and Shoulders Chart Pattern with a short term price target of 6.8usd but also a downside afterwards till $4. I`m looking forward to read your opinion about it.
If the entire market doesn't take a shit, I do think ATOS could play out this bullish formation. Broke the downtrend and retested it to perfection, now looks primed to pop up. I have put in some orders with a very tight stop loss in case the price goes south.
Not surprised that we fell hard after breaking the uptrend (green line) at $8, retested the line at $8.40 to perfection and then fell about 35% to current prices. What surprises me more is that the $5.66 support didn't hold and is now acting as a resistance zone. If we do break this mini resistance, I have no doubt that we will test the $6.60 fib region again....
This is familiar territory with ATOS . Not only is there a very clear and significant support level on the chart, there's also a multi-year level of resistance the ATOS is sitting at right now. The biggest question is Now What? " Earlier this month, Atossa revealed data from a Phase 2 Endoxifen study in breast cancer. It met primary and secondary endpoints. The...
ICKER CODE: ATOS Company Name: ATOSSA THERAPEUTICS, INC Industry: US Stocks Health Technology Medical Specialties Position Proposed: BUY FOMO BUY ENTRY: NOW READY (4.00-5.20) NEXT BUY ENTRY: (2,65 - 3.35) 1st Partial Take Profit: 140.00 (Mid 2022) 2nd Partial Take Profit: 200.00 (Mid 2024) 3RD Partial Take Profit: 320.00 (2027) 1st PARTIAL SHORT TERM TP:...